According to MRFR analysis, the global viral vector and plasmid DNA manufacturing market is expected to register a CAGR of ~16.9% from 2021 to 2027 and hold a value of ~USD 4,870 million in2027.

The global viral vector and plasmid DNA manufacturing market is driven by the rising demand for viral vector-based vaccines for infectious diseases and a shift in the treatment paradigm of several life-threatening diseases through advanced the rapies and...